DRUG · Unmapped registry intervention
The effectiveness of Xeljanz in rheumatoid arthritis patients
Find medicine records ·
Find other trials using this name
Clinical trial
Evaluation of the Condition of Rheumatoid Arthritis After Treatment
NCT02157012
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedEvaluation of the Condition of Rheumatoid Arthritis After Treatment
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Shinshu Universitylead sponsor
Showa Inan General Hospitalcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02157012 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.